SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
lucky
Lv3
248 积分
2022-01-21 加入
最近求助
最近应助
互助留言
PARP Inhibitors for Breast Cancer Treatment
24天前
已完结
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)
1个月前
已完结
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
1个月前
已完结
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
1个月前
已完结
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
1个月前
已完结
Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
1个月前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
1个月前
已完结
Diagnosis and Treatment of Metastatic Colorectal Cancer
1个月前
已完结
Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
1个月前
已完结
Current treatment options of HER2+ metastatic colorectal carcinoma
1个月前
已关闭
没有进行任何应助
不需要了【积分已退回】
1个月前
不是需要的文章
4个月前
已找到【积分已退回】
9个月前
已找到【积分已退回】
11个月前
已找到【积分已退回】
1年前
已找到【积分已退回】
1年前
已找到【积分已退回】
2年前
已找到【积分已退回】
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论